Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 9,045 | 8,382 | 7,563 | 6,657 | 8,405 |
| Operating Income | -9,045 | -8,382 | -7,563 | -6,657 | -8,405 |
| Interest Expense | 3 | 153 | 231 | 274 | 292 |
| Other Income | 1,337 | 1,360 | 1,386 | 1,406 | 424 |
| Pre-tax Income | -7,711 | -7,175 | -6,408 | -5,525 | -8,273 |
| Income Tax | -13 | -30 | -7 | -30 | -7 |
| Net Income Continuous | -7,698 | -7,145 | -6,401 | -5,495 | -8,266 |
| Net Income | $-7,698 | $-7,145 | $-6,401 | $-5,505 | $-8,266 |
| EPS Basic Total Ops | -0.08 | -0.07 | -0.06 | 0.05 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.07 | -0.06 | 0.04 | -0.12 |
| EPS Diluted Total Ops | -0.08 | -0.07 | -0.06 | 0.05 | -0.12 |
| EPS Diluted Continuous Ops | -0.08 | -0.07 | -0.06 | 0.04 | -0.12 |
| EBITDA(a) | $-9,010 | $-8,249 | $-7,463 | $-6,541 | $-8,202 |